Detalhe da pesquisa
1.
Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity.
Antimicrob Agents Chemother
; 62(8)2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29784840
2.
Does oxidative stress contribute to adverse outcomes in HIV-associated TB?
J Antimicrob Chemother
; 73(5): 1117-1120, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325139
3.
Nontuberculous Mycobacteria Infections at a Provincial Reference Hospital, Cambodia.
Emerg Infect Dis
; 23(7): 1139-1147, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28628437
4.
Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 61(7)2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28438933
5.
Oxidative stress and TB outcomes in patients with diabetes mellitus?
J Antimicrob Chemother
; 72(6): 1552-1555, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28204508
6.
Mycobacterium tuberculosis Mutations Associated with Reduced Susceptibility to Linezolid.
Antimicrob Agents Chemother
; 60(4): 2542-4, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26810645
7.
Role of the Cys154Arg Substitution in Ribosomal Protein L3 in Oxazolidinone Resistance in Mycobacterium tuberculosis.
Antimicrob Agents Chemother
; 60(5): 3202-6, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26953211
8.
Complexation of clofazimine by macrocyclic cucurbit[7]uril reduced its cardiotoxicity without affecting the antimycobacterial efficacy.
Org Biomol Chem
; 14(31): 7563-9, 2016 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27439674
9.
ATS/CDC/ERS/IDSA Clinical Practice Guidelines for Treatment of Drug-Resistant Tuberculosis: A Two-edged Sword?
Am J Respir Crit Care Med
; 202(5): 777-778, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32374633
10.
Novel drugs against tuberculosis: a clinician's perspective.
Eur Respir J
; 45(4): 1119-31, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25431273
11.
T-Spot.TB outperforms tuberculin skin test in predicting development of active tuberculosis among household contacts.
Respirology
; 20(3): 496-503, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25689894
12.
Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis.
Clin Infect Dis
; 59(10): 1364-74, 2014 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25097082
13.
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.
Eur Respir J
; 44(1): 23-63, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24659544
14.
Management of adverse reactions to high-dose moxifloxacin used in multidrug-resistant tuberculosis treatment programmes.
Respirology
; 24(3): 201-203, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30520535
15.
Can vitamin C help in managing tuberculosis associated with diabetes mellitus?
Respirology
; 24(8): 819-820, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31106929
16.
RE: "DIETARY INTAKE OF ANTIOXIDANT VITAMINS AND CAROTENOIDS AND RISK OF DEVELOPING ACTIVE TUBERCULOSIS IN A PROSPECTIVE POPULATION-BASED COHORT".
Am J Epidemiol
; 187(7): 1570-1571, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29370338
17.
Erratum for Yew et al., "Oxidative Stress and First-Line Antituberculosis Drug-Induced Hepatotoxicity".
Antimicrob Agents Chemother
; 62(10)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30249717
18.
Pyrazinamide Is a Two-Edged Sword: Do WHO Guidelines Matter?
Antimicrob Agents Chemother
; 62(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29269428
19.
WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis.
Antimicrob Agents Chemother
; 57(9): 4097-104, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23774431
20.
Vitamin C and Mycobacterium tuberculosis Persisters.
Antimicrob Agents Chemother
; 62(11)2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30355747